Don Kurtyka, PhD, ARNP, MBA
Administrative Director, HIV Services, Tampa General Hospital
Faculty, Florida/Caribbean AIDS Education and Training Center
Biographical Sketch | Areas of Expertise | Current Research | Publications
PhD, University of South Florida, College of Nursing
MS, Family Health Nursing, University of South Florida College of Nursing
MBA, Health Care Administration, Western New England College
Phone: (813) 307-8015
FAX: (813) 272-7116
He is a member of numerous organizations including the American Academy of HIV Medicine, Association of Nurses in AIDS Care, American Nurses Association, and the American Academy of Nurse Practitioners.
Areas of Expertise
Predictors of Adherence to First Provider Visit, 2009- open.
Identification and Prevalence of HIV Drug Resistance in Antiretroviral Naïve Patients in Tampa Bay, 2008-open.
SWIFT Study: A prospective, randomized, open lab el Phase IV Study to Evaluate the Rationale of Switching from Fixed Dose Abacavir (ABC)/Lamivudine (3TC) to Fixed-Dose Tenofovir DF (TDF)/Emtricitabine (FTC) in Virologically-Suppressed, HIV-1 Infected Patients Maintained on a Ritonavir-Boosted Protease Inhibitor Containing Antiretroviral Regimen, 2008.
The Effects of a Structured Adherence Intervention to HAART on Adherence and Treatment Response Outcomes, 2006-2008 (doctoral dissertation).
Kurtyka D. From Terminal Disease to Chronic Illness: HIV Infection in 2010. Advance for Nurse Practitioners, 2010: 18(1): 33-38.
Somboonwit C; Kurtyka D; Velez; AP. Abacavir and lamivudine combination. Expert Opinion on Drug Metabolism &Toxicology. 2009: 5(12):1599-1606
Acosta E; Kiser J; Kurtyka D; Walmsley S. Optimizing HIV Therapy in Patients with Multiclass Resistance. Discovery Institute of Medical Education, 2006.
Kirton C; Kurtyka D; Sterken D. New Insights into HIV Resistance Testing: Nursing Guidelines & Implications, Journal of the Association of Nurses in AIDS Care, 2007:18(3):74-86.